Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced clinical manufacturing expansion in the United Kingdom (UK) and the United States (US). Achilles
Found this useful? Share it with your team.
